Harbor Investment Advisory’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-56
Closed -$437 1215
2024
Q2
$437 Hold
56
﹤0.01% 1135
2024
Q1
$398 Hold
56
﹤0.01% 1264
2023
Q4
$375 Hold
56
﹤0.01% 1114
2023
Q3
$315 Hold
56
﹤0.01% 1140
2023
Q2
$309 Hold
56
﹤0.01% 1298
2023
Q1
$350 Hold
56
﹤0.01% 1293
2022
Q4
$261 Hold
56
﹤0.01% 1302
2022
Q3
$0 Hold
56
﹤0.01% 1345
2022
Q2
$0 Hold
56
﹤0.01% 1355
2022
Q1
$1K Hold
56
﹤0.01% 1293
2021
Q4
$2K Hold
56
﹤0.01% 1218
2021
Q3
$2K Hold
56
﹤0.01% 1230
2021
Q2
$2K Hold
56
﹤0.01% 1178
2021
Q1
$2K Hold
56
﹤0.01% 1167
2020
Q4
$2K Buy
+56
New +$2.57K ﹤0.01% 1101

Other funds holding GDRX

Harbor Investment Advisory's GDRX Position: Q3 2024 in Review

Harbor Investment Advisory sold out of GoodRx Holdings (GDRX) in Q3 2024, closing a stake of 56 shares — an estimated $437 sold.

Harbor Investment Advisory first reported a position in GDRX in Q4 2020 and held it in 15 quarters. The position peaked at $2K in Q4 2021. 168 funds tracked by Wall St. Rank hold GDRX as of Q3 2024.

  • Harbor Investment Advisory reported no remaining GoodRx Holdings position as of Q3 2024 after selling out during the quarter.
  • Harbor Investment Advisory sold 56 GoodRx Holdings shares in Q3 2024, an estimated $437.
  • Harbor Investment Advisory first reported a position in GoodRx Holdings in Q4 2020 and held it in 15 quarters.
  • Harbor Investment Advisory's GoodRx Holdings position peaked at $2K in Q4 2021.
  • 168 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2024.

Based on Harbor Investment Advisory's 13F filing for Q3 2024, filed 4 Oct 2024.